Urokinase plasminogen activator induces pro-fibrotic/m2 phenotype in murine cardiac macrophages. 2013

Jessica Meznarich, and Laura Malchodi, and Deri Helterline, and Stephen A Ramsey, and Kate Bertko, and Tabitha Plummer, and Abigail Plawman, and Elizabeth Gold, and April Stempien-Otero
University of Washington School of Medicine, Division of Cardiology, Seattle, Washington, United States of America.

OBJECTIVE Inflammation and fibrosis are intertwined in multiple disease processes. We have previously found that over-expression of urokinase plasminogen activator in macrophages induces spontaneous macrophage accumulation and fibrosis specific to the heart in mice. Understanding the relationship between inflammation and fibrosis in the heart is critical to developing therapies for diverse myocardial diseases. Therefore, we sought to determine if uPA induces changes in macrophage function that promote cardiac collagen accumulation. RESULTS We analyzed the effect of the uPA transgene on expression of pro-inflammatory (M1) and pro-fibrotic (M2) genes and proteins in hearts and isolated macrophages of uPA overexpressing mice. We found that although there was elevation of the pro-inflammatory cytokine IL-6 in hearts of transgenic mice, IL-6 is not a major effector of uPA induced cardiac fibrosis. However, uPA expressing bone marrow-derived macrophages are polarized to express M2 genes in response to IL-4 stimulation, and these M2 genes are upregulated in uPA expressing macrophages following migration to the heart. In addition, while uPA expressing macrophages express a transcriptional profile that is seen in tumor-associated macrophages, these macrophages promote collagen expression in cardiac but not embryonic fibroblasts. CONCLUSIONS Urokinase plasminogen activator induces an M2/profibrotic phenotype in macrophages that is fully expressed after migration of macrophages into the heart. Understanding the mechanisms by which uPA modulates macrophage function may reveal insights into diverse pathologic processes.

UI MeSH Term Description Entries
D008262 Macrophage Activation The process of altering the morphology and functional activity of macrophages so that they become avidly phagocytic. It is initiated by lymphokines, such as the macrophage activation factor (MAF) and the macrophage migration-inhibitory factor (MMIF), immune complexes, C3b, and various peptides, polysaccharides, and immunologic adjuvants. Activation, Macrophage,Activations, Macrophage,Macrophage Activations
D008264 Macrophages The relatively long-lived phagocytic cell of mammalian tissues that are derived from blood MONOCYTES. Main types are PERITONEAL MACROPHAGES; ALVEOLAR MACROPHAGES; HISTIOCYTES; KUPFFER CELLS of the liver; and OSTEOCLASTS. They may further differentiate within chronic inflammatory lesions to EPITHELIOID CELLS or may fuse to form FOREIGN BODY GIANT CELLS or LANGHANS GIANT CELLS. (from The Dictionary of Cell Biology, Lackie and Dow, 3rd ed.) Bone Marrow-Derived Macrophages,Monocyte-Derived Macrophages,Macrophage,Macrophages, Monocyte-Derived,Bone Marrow Derived Macrophages,Bone Marrow-Derived Macrophage,Macrophage, Bone Marrow-Derived,Macrophage, Monocyte-Derived,Macrophages, Bone Marrow-Derived,Macrophages, Monocyte Derived,Monocyte Derived Macrophages,Monocyte-Derived Macrophage
D008822 Mice, Transgenic Laboratory mice that have been produced from a genetically manipulated EGG or EMBRYO, MAMMALIAN. Transgenic Mice,Founder Mice, Transgenic,Mouse, Founder, Transgenic,Mouse, Transgenic,Mice, Transgenic Founder,Transgenic Founder Mice,Transgenic Mouse
D009206 Myocardium The muscle tissue of the HEART. It is composed of striated, involuntary muscle cells (MYOCYTES, CARDIAC) connected to form the contractile pump to generate blood flow. Muscle, Cardiac,Muscle, Heart,Cardiac Muscle,Myocardia,Cardiac Muscles,Heart Muscle,Heart Muscles,Muscles, Cardiac,Muscles, Heart
D010641 Phenotype The outward appearance of the individual. It is the product of interactions between genes, and between the GENOTYPE and the environment. Phenotypes
D002465 Cell Movement The movement of cells from one location to another. Distinguish from CYTOKINESIS which is the process of dividing the CYTOPLASM of a cell. Cell Migration,Locomotion, Cell,Migration, Cell,Motility, Cell,Movement, Cell,Cell Locomotion,Cell Motility,Cell Movements,Movements, Cell
D003094 Collagen A polypeptide substance comprising about one third of the total protein in mammalian organisms. It is the main constituent of SKIN; CONNECTIVE TISSUE; and the organic substance of bones (BONE AND BONES) and teeth (TOOTH). Avicon,Avitene,Collagen Felt,Collagen Fleece,Collagenfleece,Collastat,Dermodress,Microfibril Collagen Hemostat,Pangen,Zyderm,alpha-Collagen,Collagen Hemostat, Microfibril,alpha Collagen
D005347 Fibroblasts Connective tissue cells which secrete an extracellular matrix rich in collagen and other macromolecules. Fibroblast
D005355 Fibrosis Any pathological condition where fibrous connective tissue invades any organ, usually as a consequence of inflammation or other injury. Cirrhosis,Fibroses
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia

Related Publications

Jessica Meznarich, and Laura Malchodi, and Deri Helterline, and Stephen A Ramsey, and Kate Bertko, and Tabitha Plummer, and Abigail Plawman, and Elizabeth Gold, and April Stempien-Otero
July 2017, Journal of molecular and cellular cardiology,
Jessica Meznarich, and Laura Malchodi, and Deri Helterline, and Stephen A Ramsey, and Kate Bertko, and Tabitha Plummer, and Abigail Plawman, and Elizabeth Gold, and April Stempien-Otero
July 2021, Toxicon : official journal of the International Society on Toxinology,
Jessica Meznarich, and Laura Malchodi, and Deri Helterline, and Stephen A Ramsey, and Kate Bertko, and Tabitha Plummer, and Abigail Plawman, and Elizabeth Gold, and April Stempien-Otero
December 1987, Biochemistry,
Jessica Meznarich, and Laura Malchodi, and Deri Helterline, and Stephen A Ramsey, and Kate Bertko, and Tabitha Plummer, and Abigail Plawman, and Elizabeth Gold, and April Stempien-Otero
October 1996, Infection and immunity,
Jessica Meznarich, and Laura Malchodi, and Deri Helterline, and Stephen A Ramsey, and Kate Bertko, and Tabitha Plummer, and Abigail Plawman, and Elizabeth Gold, and April Stempien-Otero
November 1996, European journal of biochemistry,
Jessica Meznarich, and Laura Malchodi, and Deri Helterline, and Stephen A Ramsey, and Kate Bertko, and Tabitha Plummer, and Abigail Plawman, and Elizabeth Gold, and April Stempien-Otero
October 1994, The Journal of biological chemistry,
Jessica Meznarich, and Laura Malchodi, and Deri Helterline, and Stephen A Ramsey, and Kate Bertko, and Tabitha Plummer, and Abigail Plawman, and Elizabeth Gold, and April Stempien-Otero
May 2014, The Journal of biological chemistry,
Jessica Meznarich, and Laura Malchodi, and Deri Helterline, and Stephen A Ramsey, and Kate Bertko, and Tabitha Plummer, and Abigail Plawman, and Elizabeth Gold, and April Stempien-Otero
May 1995, International journal of cancer,
Jessica Meznarich, and Laura Malchodi, and Deri Helterline, and Stephen A Ramsey, and Kate Bertko, and Tabitha Plummer, and Abigail Plawman, and Elizabeth Gold, and April Stempien-Otero
October 2006, The Journal of biological chemistry,
Jessica Meznarich, and Laura Malchodi, and Deri Helterline, and Stephen A Ramsey, and Kate Bertko, and Tabitha Plummer, and Abigail Plawman, and Elizabeth Gold, and April Stempien-Otero
September 1989, Thrombosis and haemostasis,
Copied contents to your clipboard!